|
|
||||||||
Temple University School of Medicine
Philadelphia, Pennsylvania
Johns Hopkins University Bloomberg
School of Public Health
Baltimore, Maryland
The National Emphysema Treatment Trial (NETT) is a multicenter, randomized, controlled trial comparing optimal medical treatment, including pulmonary rehabilitation, with optimal medical treatment plus lung volume reduction surgery. A total of 1,218 patients were randomized to one of the two treatment arms and then followed for a minimum of 6 months (maximum of 5 yr). Resources permitted patient follow-up to continue for an additional 1.5 years to capture additional long-term survival and quality-of-life data, and data analysis to continue for 3 years after that, thus extending the duration of NETT operation to more than a decade. As a result, the NETT is the largest, longest, and most comprehensive examination of the evaluation and treatment of emphysema ever conducted. Over its period of operation, the NETT has had many unique features as follows:
The NETT also provided many lessons regarding the care of the patient with emphysema as follows:
This issue of the Proceedings of the American Thoracic Society is a comprehensive compendium of state-of-the-art care of emphysema by the NETT investigators based on their experience managing patients enrolled in the NETT. The information goes well beyond our knowledge gained about lung volume reduction surgery or pulmonary care, and includes the lessons learned about the total overall care of the patients with emphysema. Our intent is that this information will be a useful resource for clinicians who care for patients with severe emphysema and serve as a reference to those who plan to conduct future clinical investigation in this extremely impaired and complexly ill patient group.
The success of the NETT was due to the combined efforts of dedicated teams of physicians, coordinators, nurses, therapists, researchers, and expanded ancillary staff from a variety of medical institutions across the country. The NETT Data Coordinating Center and the project officers from the National Heart, Lung, and Blood Institute, the CMS, and the Agency for Healthcare Research and Quality led these teams in NETT study design and operation. We recognize the extreme dedication and cooperation of the patients who enrolled into the NETT. It is to our patients that we dedicate this supplement.
ACKNOWLEDGMENTS
The editors of this supplement would also like to acknowledge the editorial contributions of Susan Tonascia, Sc.M., in helping us complete this work.
FOOTNOTES
Conflict of Interest Statement: G.J.C. has had grant support from Emphasys and Aeris Therapeutics. A.L.S. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript.
| ||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |